PHARMACY

FDA approves Perrigo testosterone gel

BY Alaric DeArment

ALLEGAN, Mich. — The Food and Drug Administration has approved a testosterone gel product made by Perrigo, the drug maker said Tuesday.

Perrigo announced the approval of the testosterone gel in the 1% strength for the treatment of men with low or no testosterone.

The drug is bioequivalent to AbbVie’s AndroGel, which has annual sales of about $705 million, according to Symphony Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Rx Timer Cap introduces easy-to-remove version

BY Alaric DeArment

LOS ANGELES — Rx Timer Cap has introduced a new version of the cap designed for ease of use among elderly patients.

The company announced Tuesday the introduction of the new EZ-Twist removal system for making the cap easy to open and close for people who don’t require childproof caps.

Like the original Rx Timer Cap, the EZ-Twist cap includes a built-in LCD timer that automatically counts the minutes and hours since the patient last took his or her medication. The cap’s bold red color differentiates it from the original, child-resistant cap, and the cap fits the Rexam Screw-Loc and Berry Friendly & Safe vials.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

CueScript launches patient engagement, medication adherence tool for pharmacy

BY Michael Johnsen

LAKE MARY, Fla. — CueScript on Tuesday launched an innovative platform that delivers on-demand prescription-specific videos and other value-added services designed to engage patients, improve health literacy and improve medication adherence. 

“When patients are empowered with reliable and understandable information, they make better decisions about their health. This is particularly true when it comes to medications,” stated David Medvedeff, CueScript CEO. “Patient education remains a top priority for pharmacists and other healthcare providers. CueScript now provides an innovative and highly accessible extension of the education process that drives patient engagement and reinforces the patient-provider relationship.” 

CueScript has developed a patient engagement gateway that helps to improve health literacy by providing an alternative source of trusted medication information. The gateway also extends the pharmacist’s or provider’s reach by giving patients and their caregivers easy access to important medication information. 

CueScript utilizes QR codes, SMS text messaging and email to connect patients and their caregivers with advanced mobile, web and on-demand video technologies to deliver contemporary education and information tools. It starts with the CueScript video library, which provides information on top-prescribed medications, including proper usage, expected benefits and potential side effects. Available in English and Spanish, videos are developed by a team of Doctors of Pharmacy with nearly 50 years of combined experience educating patients in both acute care and retail settings. 

“Connecting patients with on-demand video briefings is just the first point of engagement,” Medvedeff said. “It sets the stage for pharmacies and healthcare organizations to leverage the value-added services that are the real power of the CueScript platform," he said. “By serving as an extension of the provider, our innovative technology and trusted clinical content creates an informed and engaged patient and loyal customer.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?